IFNGR1 and graft versus host disease: We were the first to report that upregulated IFNGR signaling in activated T cells contributes to GvHD development, and its genetic deletion in donor T cells significantly improves overall survival and GvHD without compromising GvL effects in vivo [12,13,25].